Status:

UNKNOWN

Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis

Lead Sponsor:

Assiut University

Conditions:

Ulcerative Colitis Chronic

Eligibility:

All Genders

18-60 years

Phase:

PHASE2

PHASE3

Brief Summary

My study aims to directly compare the efficacy and safety of Budesonide MMX versus Prednisolone in the management of mild to moderate cases of ulcerative colitis.

Detailed Description

It is a randomized clinical trial where patients with mild to moderate ulcerative colitis who failed to respond to conventional therapy with mesalazine will randomly be divided into two groups one of ...

Eligibility Criteria

Inclusion

  • This study will include patients with confirmed mild to moderate ulcerative colitis according to the Mayo score activity index with ages ranging between 18-60 years old.

Exclusion

  • Patients \< 18 years old.
  • Pregnant females.
  • Patients with proven infection with any enteric pathogens (e.g., Shigella species, Clostridium species, Salmonella species, ova, parasites, Clostridium difficile toxins A or B, or HIV infection).
  • Patients who received oral or rectal steroids in the last 4 weeks, immunosuppressive agents in the last 8 weeks, or anti-tumor necrosis factor agents in the last 3 months.
  • Patients with severe colitis (Mayo score \>11); Patients with evidence or history of toxic megacolon.
  • Severe anemia (hemoglobin \<10.5 g/dl), leucopenia, or granulocytopenia.
  • Patients using any cytochrome P450 inducers or inhibitors (e.g., ketoconazole, phenytoin) or antibiotics.
  • Patients with renal disease/insufficiency.
  • Patients with type I diabetes.
  • Patients with glaucoma.
  • Patients with malignancies.
  • Patients with decompensated liver cirrhosis (Child-Pugh score B and C).
  • Patients with COVID 19 infection.

Key Trial Info

Start Date :

June 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2024

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05341401

Start Date

June 1 2022

End Date

June 1 2024

Last Update

April 22 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.